| Peroxisome proliferator‐activated receptor δ controls muscle development and oxydative capability S Luquet, J Lopez‐Soriano, D Holst, A Fredenrich, J Melki, ... The FASEB Journal 17 (15), 2299-2301, 2003 | 688 | 2003 |
| Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes S Luquet, C Gaudel, D Holst, J Lopez-Soriano, C Jehl-Pietri, A Fredenrich, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1740 (2), 313-317, 2005 | 299 | 2005 |
| Cross‐talk between skeletal muscle and adipose tissue: a link with obesity? JM Argilés, J López‐Soriano, V Almendro, S Busquets, FJ López‐Soriano Medicinal research reviews 25 (1), 49-65, 2005 | 251 | 2005 |
| Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats N Carbo, J Lopez-Soriano, P Costelli, S Busquets, B Alvarez, FM Baccino, ... British journal of cancer 83 (4), 526-531, 2000 | 220 | 2000 |
| Journey from cachexia to obesity by TNF JM Argilés, J López‐Soriano, S Busquets, FJ López‐Soriano The FASEB journal 11 (10), 743-751, 1997 | 203 | 1997 |
| Roles of peroxisome proliferator-activated receptor delta (PPARδ) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome S Luquet, J Lopez-Soriano, D Holst, C Gaudel, C Jehl-Pietri, A Fredenrich, ... Biochimie 86 (11), 833-837, 2004 | 147 | 2004 |
| Serum haptoglobin: a novel marker of adiposity in humans C Chiellini, F Santini, A Marsili, P Berti, A Bertacca, C Pelosini, ... The Journal of Clinical Endocrinology & Metabolism 89 (6), 2678-2683, 2004 | 144 | 2004 |
| TNFα induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway F Marques-Fernandez, L Planells-Ferrer, R Gozzelino, KMO Galenkamp, ... Cell death & disease 4 (2), e493-e493, 2013 | 79 | 2013 |
| Leptin and tumor growth in rats J López‐Soriano, N Carbó, L Tessitore, FJ López‐Soriano, JM Argilés International journal of cancer 81 (5), 726-729, 1999 | 61 | 1999 |
| Comparative effects of β2-adrenergic agonists on muscle waste associated with tumour growth N Carbó, J López-Soriano, T Tarragó, O González, M Llovera, ... Cancer letters 115 (1), 113-118, 1997 | 57 | 1997 |
| Fas apoptosis inhibitory molecules: more than death‐receptor antagonists in the nervous system L Planells‐Ferrer, J Urresti, E Coccia, KMO Galenkamp, I Calleja‐Yagüe, ... Journal of neurochemistry 139 (1), 11-21, 2016 | 54 | 2016 |
| Cytokines and Diabetes: The Final Step? JM Argiles, J Lopez-Soriano, FJ Lopez-Soriano Hormone and metabolic research 26 (10), 447-449, 1994 | 53 | 1994 |
| Amyloid-β reduces the expression of neuronal FAIM-L, thereby shifting the inflammatory response mediated by TNFα from neuronal protection to death P Carriba, S Jimenez, V Navarro, I Moreno-Gonzalez, ... Cell death & disease 6 (2), e1639-e1639, 2015 | 48 | 2015 |
| Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity J López-Soriano, C Chiellini, M Maffei, PA Grimaldi, JM Argilés Endocrine reviews 27 (3), 318-329, 2006 | 48 | 2006 |
| FAIM-L is an IAP-binding protein that inhibits XIAP ubiquitinylation and protects from Fas-induced apoptosis RS Moubarak, L Planells-Ferrer, J Urresti, S Reix, MF Segura, P Carriba, ... Journal of Neuroscience 33 (49), 19262-19275, 2013 | 33 | 2013 |
| Interleukin-1 and β-cell function: more than one second messenger? JM Argilés, J López-Soriano, MA Ortiz, JM Pou, FJ López-Soriano Endocrine reviews 13 (3), 515-524, 1992 | 33 | 1992 |
| TNFα sensitizes neuroblastoma cells to FasL-, cisplatin-and etoposide-induced cell death by NF-κB-mediated expression of Fas KMO Galenkamp, P Carriba, J Urresti, L Planells-Ferrer, E Coccia, ... Molecular cancer 14, 1-14, 2015 | 32 | 2015 |
| Lipid metabolism in rats bearing the Yoshida AH-130 ascites hepatoma J López-Soriano, JM Argilés, FJ López-Soriano Molecular and cellular biochemistry 165, 17-23, 1996 | 29 | 1996 |
| Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth P Costelli, M Llovera, J López-Soriano, N Carbó, L Tessitore, ... Cancer letters 97 (1), 25-32, 1995 | 27 | 1995 |
| Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat J Lopez-Soriano, FJ Lopez-Soriano, GJ Bagby, DH Williamson, ... American Journal of Physiology-Endocrinology and Metabolism 272 (4), E656-E660, 1997 | 26 | 1997 |
